RNA sequencing analysis may yield better diagnosis, targeted treatment of pediatric B-acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, representing more than 30% of all pediatric cases. A pilot study in The Journal of Molecular Diagnostics confirms the feasibility of implementing an RNA sequencing analysis (RNA-Seq) workflow for clinical diagnosis of molecular subtypes in pediatric B-acute lymphoblastic leukemia (B-ALL).

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart